17183709_2|17183709|82|#section_info|324:585|Here we show that that the intestinal GATA transcription factor ELT-2 is required for both immunity to Salmonella enterica and expression of a C-type lectin gene, clec-67, which is expressed in the intestinal cells and is a good marker of S. enterica infection.|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_5|17183709|82|#section_info|586:714|We also found that ELT-2 is required for immunity to Pseudomonas aeruginosa, Enterococcus faecalis, and Cryptococcus neoformans.|#main_body|GO:0019732|antifungal humoral response|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_6|17183709|82|#section_info|715:894|Lack of immune inhibition by DAF-2, which negatively regulates the FOXO transcription factor DAF-16, rescues the hypersusceptibility to pathogens phenotype of elt-2(RNAi) animals.|#main_body|GO:0006968|cellular defense response|#go_definition|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_7|17183709|82|#section_info|715:894|Lack of immune inhibition by DAF-2, which negatively regulates the FOXO transcription factor DAF-16, rescues the hypersusceptibility to pathogens phenotype of elt-2(RNAi) animals.|#main_body|GO:0032834|positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response|Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.|IGI|GOA|daf-2(175410)|#gene_synonym
17183709_8|17183709|82|#section_info|895:1054|Our results indicate that ELT-2 is part of a multi-pathogen defense pathway that regulates innate immunity independently of the DAF-2/DAF-16 signaling pathway.|#main_body|GO:0098542|defense response to other organism|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_12|17183709|3454|#section_info|157:389|Here we show that disruption of ELT-2 causes nematodes to become hypersusceptible to Salmonella enterica-mediated killing and that ELT-2 upregulates the expression of clec-67 which is a marker of S. enterica infection in C. elegans.|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_14|17183709|3454|#section_info|390:666|Our results also suggest that ELT-2 is part of a multi-pathogen defense pathway that regulates innate immunity not only to S. enterica and Pseudomonas aeruginosa, but also to the Gram-positive bacterium Enterococcus faecalis and to the fungal pathogen Cryptococcus neoformans.|#main_body|GO:0061760|antifungal innate immune response|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_15|17183709|3454|#section_info|667:776|We also show that ELT-2 functions in C. elegans immunity independently of the DAF-2/DAF-16 signaling pathway.|#main_body|GO:0002228|natural killer cell mediated immunity|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_18|17183709|3454|#section_info|777:889|These data indicate that ELT-2 is an important regulator of a conserved C. elegans immune response to pathogens.|#main_body|GO:0009682|induced systemic resistance|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_27|17183709|9874|#section_info|0:99|ELT-2 controls expression of clec-67 which is a marker of C. elegans immune response to S. enterica|#main_body|GO:0060994|regulation of transcription from RNA polymerase II promoter involved in kidney development|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_30|17183709|10800|#section_info|453:676|Figure 2B also shows that when elt-2 expression is ablated by RNAi, clec-67 is downregulated compared to vector control, indicating that ELT-2 regulates the expression of this effector of C. elegans immunity to S. enterica.|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_31|17183709|10800|#section_info|1142:1297|Therefore, the change in the expression pattern of clec-67 is due to changes in ELT-2 levels, and not to nonspecific changes in intestinal gene expression.|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_32|17183709|12098|#section_info|0:84|ELT-2 is required for proper C. elegans immunity to a variety of microbial pathogens|#main_body|GO:0090714|innate immunity memory response|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_35|17183709|12183|#section_info|0:474|To determine whether ELT-2 is part of an immune system specific to S. enterica or whether it is required for immunity to pathogens in general, elt-2(RNAi) animals were infected with the Gram-negative bacterial pathogen P. aeruginosa [35], the Gram-positive bacterial pathogen E. faecalis [30], and the fungal pathogen C. neoformans [36] as described. For all of these pathogens, elt-2(RNAi) animals exhibit increased mortality compared to vector control animals (Figure 3). |#main_body|GO:0019732|antifungal humoral response|#go_definition|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_38|17183709|12183|#section_info|0:612|To determine whether ELT-2 is part of an immune system specific to S. enterica or whether it is required for immunity to pathogens in general, elt-2(RNAi) animals were infected with the Gram-negative bacterial pathogen P. aeruginosa [35], the Gram-positive bacterial pathogen E. faecalis [30], and the fungal pathogen C. neoformans [36] as described. For all of these pathogens, elt-2(RNAi) animals exhibit increased mortality compared to vector control animals (Figure 3). These data indicate that RNAi ablation of elt-2 increases C. elegans susceptibility to different types of bacterial and fungal pathogens.|#main_body|GO:0009817|defense response to fungus, incompatible interaction|#go_definition|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_39|17183709|12795|#section_info|862:1100|As shown in Figure 4, daf-2(e1370) mutants are more resistant not only to S. enterica and E. faecalis, as previously shown [40], but also to Cryptococcus neoformans, indicating that DAF-2 regulates immune response to pathogens in general.|#main_body|GO:0002717|positive regulation of natural killer cell mediated immunity|Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.|IMP|GOA|daf-2(175410)|#gene_synonym
17183709_40|17183709|12795|#section_info|1101:1305|Furthermore, this increased resistance to C. neoformans is dependent upon DAF-16 function as daf-2(e1370);daf-16(RNAi) nematodes have increased mortality when compared to daf-2(e1370) mutants (Figure 4D).|#main_body|GO:0060340|positive regulation of type I interferon-mediated signaling pathway|Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.|IMP|GOA|daf-2(175410)|#gene_synonym
17183709_41|17183709|12795|#section_info|1101:1305|Furthermore, this increased resistance to C. neoformans is dependent upon DAF-16 function as daf-2(e1370);daf-16(RNAi) nematodes have increased mortality when compared to daf-2(e1370) mutants (Figure 4D).|#main_body|GO:1905035|negative regulation of antifungal innate immune response|Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.|IGI|GOA|daf-16(172981)|#gene_synonym
17183709_42|17183709|14101|#section_info|391:532|However, the daf-2(e1370); elt-2(RNAi) nematodes are significantly more resistant to all pathogens tested than elt-2 RNAi animals (Figure 4).|#main_body|GO:1905682|positive regulation of innate immunity memory response|Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.|IGI|GOA|daf-2(175410)|#gene_synonym
17183709_43|17183709|14101|#section_info|391:532|However, the daf-2(e1370); elt-2(RNAi) nematodes are significantly more resistant to all pathogens tested than elt-2 RNAi animals (Figure 4).|#main_body|GO:1902478|negative regulation of defense response to bacterium, incompatible interaction|Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.|IGI|GOA|elt-2(181250)|#gene_synonym
17183709_44|17183709|14101|#section_info|533:770|Interestingly, daf-2(e1370); elt-2(RNAi) animals have increased resistance to E. faecalis compared to daf-2(e1370) animals, indicating that ELT-2 may suppress immune defenses specific to E. faecalis that are typically inhibited by DAF-2.|#main_body|GO:0001870|positive regulation of complement activation, lectin pathway|Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.|IGI|GOA|daf-2(175410)|#gene_synonym
17183709_46|17183709|14101|#section_info|771:947|Control experiments indicate that daf-2(e1370);daf-16(RNAi) animals have increased susceptibility to all pathogens when compared to daf-2(e1370) (Figure 4D and data not shown).|#main_body|GO:0002716|negative regulation of natural killer cell mediated immunity|Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.|IGI|GOA|daf-16(172981)|#gene_synonym
17183709_47|17183709|15060|#section_info|0:244|Our results suggest that the GATA transcription factor ELT-2 regulates a C. elegans innate immunity independently of DAF-2/DAF-16 and that it regulates the expression of clec-67 which is a marker of C. elegans immunity to S. enterica infection.|#main_body|GO:0090714|innate immunity memory response|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_50|17183709|15060|#section_info|0:244|Our results suggest that the GATA transcription factor ELT-2 regulates a C. elegans innate immunity independently of DAF-2/DAF-16 and that it regulates the expression of clec-67 which is a marker of C. elegans immunity to S. enterica infection.|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_51|17183709|15060|#section_info|351:761|Since DAF-16 does not appear to be required for immunity to bacterial [40] and fungal pathogens (Figure 4C), the ELT-2 requirement for proper immunity to bacterial and fungal pathogens described here provides one of the first direct evidences indicating that a C. elegans transcription factor is required not only for the expression of immunity-related genes but also for survival in the presence of pathogens.|#main_body|GO:0140367|antibacterial innate immune response|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_52|17183709|15060|#section_info|351:761|Since DAF-16 does not appear to be required for immunity to bacterial [40] and fungal pathogens (Figure 4C), the ELT-2 requirement for proper immunity to bacterial and fungal pathogens described here provides one of the first direct evidences indicating that a C. elegans transcription factor is required not only for the expression of immunity-related genes but also for survival in the presence of pathogens.|#main_body|GO:0061760|antifungal innate immune response|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_53|17183709|16981|#section_info|404:496|We show here that like DAF-16, ELT-2 appears to regulate the expression of immune effectors.|#main_body|GO:0070816|phosphorylation of RNA polymerase II C-terminal domain|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_56|17183709|16981|#section_info|404:635|We show here that like DAF-16, ELT-2 appears to regulate the expression of immune effectors. In addition, it seems to be required for survival in the presence of Gram-negative bacteria, Gram-positive bacteria, and fungal pathogens.|#main_body|GO:0009817|defense response to fungus, incompatible interaction|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_57|17183709|16981|#section_info|636:964|Lack of immune inhibition by DAF-2 rescues, fully or partially, the hypersusceptibility to pathogens phenotype of elt-2(RNAi) animals suggesting both that elt-2(RNAi) animals do not have developmental defects that make them more susceptible to pathogens and that ELT-2 acts upstream or independently of the DAF-2/DAF-16 pathway.|#main_body|GO:0060340|positive regulation of type I interferon-mediated signaling pathway|Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.|IGI|GOA|daf-2(175410)|#gene_synonym
17183709_58|17183709|16981|#section_info|636:964|Lack of immune inhibition by DAF-2 rescues, fully or partially, the hypersusceptibility to pathogens phenotype of elt-2(RNAi) animals suggesting both that elt-2(RNAi) animals do not have developmental defects that make them more susceptible to pathogens and that ELT-2 acts upstream or independently of the DAF-2/DAF-16 pathway.|#main_body|GO:0009616|virus induced gene silencing|#go_definition|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_61|17183709|16981|#section_info|965:1217|The facts that RNAi ablation of ELT-2 results in an increased susceptibility to pathogens and that RNAi ablation of DAF-16 (Figure 4) or mutations in daf-16 [40] does not affect the susceptibility to pathogens argue in favor of the second possibility. |#main_body|GO:0002357|defense response to tumor cell|#go_definition|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_62|17183709|16981|#section_info|1217:1412|Taken together, our results indicate that DAF-16 and ELT-2 are two key transcription factors that regulate two independent pathways required for C. elegans innate immunity to microbial pathogens.|#main_body|GO:0009682|induced systemic resistance|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_65|17183709|33854|#section_info|0:45|Expression of clec-67 is controlled by ELT-2.|#main_body|GO:0070816|phosphorylation of RNA polymerase II C-terminal domain|#go_definition|NONE|GOA|elt-2(181250)|#gene_synonym
17183709_66|17183709|34799|#section_info|0:92|elt-2(RNAi) animals are more susceptible than wild-type nematodes to a variety of pathogens.|#main_body|GO:0006954|inflammatory response|#go_definition|IMP|GOA|elt-2(181250)|#gene_synonym
17183709_67|17183709|35499|#section_info|0:109|The daf-2(e1370) mutation rescues the increased susceptibility to pathogens phenotype of elt-2(RNAi) animals.|#main_body|GO:1900245|positive regulation of MDA-5 signaling pathway|Any process that activates or increases the frequency, rate or extent of a defense response.|IGI|GOA|daf-2(175410)|#gene_synonym
17183709_68|17183709|35499|#section_info|0:109|The daf-2(e1370) mutation rescues the increased susceptibility to pathogens phenotype of elt-2(RNAi) animals.|#main_body|GO:0110133|negative regulation of CRISPR-cas system|Any process that stops, prevents, or reduces the frequency, rate or extent of a defense response.|IMP|GOA|elt-2(181250)|#gene_synonym
